{"title":"A case of transient elevation of creatinine caused by severe hyperuricemia.","authors":"Qiong Wu, Yumeng Gao, Xinyuan Zhang, Wenbo Cui, Shumin Li, Chunyu Luo, Dianjun Mo, Xinqi Cheng","doi":"10.1016/j.cca.2024.120110","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To explore the underlying causes of significant fluctuations in creatinine levels within three days due to transient and severe uric acid elevation, and to provide evidence for the interpretation of abnormal test results and clinical diagnosis and management.</p><p><strong>Methods: </strong>The issues were resolved by retesting the samples, comparing results across different detection platforms, and analyzing the reaction curve. We comprehensively reviewed patients' general conditions, imaging examinations, and treatments. Additionally, we compared pre- and post-admission changes in laboratory indices and performed an extensive literature search for comprehensive analysis.</p><p><strong>Results: </strong>At the patient's first visit, the levels of uric acid (UA), creatinine (CR), and urea (UREA) were measured at 891 umol/L, 211 umol/L, and 7.8 mmol/L, respectively using a Roche full-automatic biochemical analyzer and its corresponding reagents. Subsequent testing yielded 917 umol/L, 211 umol/L, and 8.3 mmol/L for UA, CR, and UREA. After retesting with the Beckman automatic biochemical analyzer and its corresponding reagents, the results for UA, CR, and UREA were 1013 umol/L, 221 umol/L, and 7.75 mmol/L, respectively. The results of the two detection systems were in agreement. A supplementary measurement of Cystatin C (CYSC) at 1.69 mg/L indicates renal dysfunction, consistent with the observed increase in CR levels and ruling out false elevation due to assay-related issues. At 48 h post-admission, untreated, the levels of blood UA, CR, and UREA decreased to 567umol/L, 77umol/L, and 5.1 mmol/L, respectively. Through literature review and analysis, it was determined that the transient abnormal increase in the patient's creatinine level may be attributed to a substantial accumulation of uric acid crystals obstructing the renal tubules, leading to an impediment in renal tubular excretion which subsequently resolves spontaneously.</p><p><strong>Conclusion: </strong>Severe hyperuricemia may result in a transient increase in blood CR levels and could potentially lead to the development of acute uric acid nephropathy. When a clinical laboratory encounters test results inconsistent with the clinical manifestations, it is essential to not only address any potential detection issues but also proactively investigate the underlying reasons for abnormal test results through comprehensive literature reviews and other rigorous methodologies.</p>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":" ","pages":"120110"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cca.2024.120110","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To explore the underlying causes of significant fluctuations in creatinine levels within three days due to transient and severe uric acid elevation, and to provide evidence for the interpretation of abnormal test results and clinical diagnosis and management.
Methods: The issues were resolved by retesting the samples, comparing results across different detection platforms, and analyzing the reaction curve. We comprehensively reviewed patients' general conditions, imaging examinations, and treatments. Additionally, we compared pre- and post-admission changes in laboratory indices and performed an extensive literature search for comprehensive analysis.
Results: At the patient's first visit, the levels of uric acid (UA), creatinine (CR), and urea (UREA) were measured at 891 umol/L, 211 umol/L, and 7.8 mmol/L, respectively using a Roche full-automatic biochemical analyzer and its corresponding reagents. Subsequent testing yielded 917 umol/L, 211 umol/L, and 8.3 mmol/L for UA, CR, and UREA. After retesting with the Beckman automatic biochemical analyzer and its corresponding reagents, the results for UA, CR, and UREA were 1013 umol/L, 221 umol/L, and 7.75 mmol/L, respectively. The results of the two detection systems were in agreement. A supplementary measurement of Cystatin C (CYSC) at 1.69 mg/L indicates renal dysfunction, consistent with the observed increase in CR levels and ruling out false elevation due to assay-related issues. At 48 h post-admission, untreated, the levels of blood UA, CR, and UREA decreased to 567umol/L, 77umol/L, and 5.1 mmol/L, respectively. Through literature review and analysis, it was determined that the transient abnormal increase in the patient's creatinine level may be attributed to a substantial accumulation of uric acid crystals obstructing the renal tubules, leading to an impediment in renal tubular excretion which subsequently resolves spontaneously.
Conclusion: Severe hyperuricemia may result in a transient increase in blood CR levels and could potentially lead to the development of acute uric acid nephropathy. When a clinical laboratory encounters test results inconsistent with the clinical manifestations, it is essential to not only address any potential detection issues but also proactively investigate the underlying reasons for abnormal test results through comprehensive literature reviews and other rigorous methodologies.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.